Complete molecular remission in chronic myelogenous leukemia after imatinib therapy

被引：33
作者：
Barbany, G
Höglund, M
Simonsson, B
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 347卷 / 07期
关键词：
D O I：
10.1056/NEJM200208153470719
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：539 / 540
页数：2
相关论文
共 5 条
[1]  
Barbany G, 2000, CLIN CHEM, V46, P913
[2]   Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].
Druker, BJ ;
Sawyers, CL ;
Kantarjian, H ;
Resta, DJ ;
Reese, SF ;
Ford, JM ;
Capdeville, R ;
Talpaz, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042
[3]   Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037
[4]   Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors [J].
Sawyers, CL .
SEMINARS IN HEMATOLOGY, 2001, 38 (03) :15-21
[5]   Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction [J].
Stentoft, J ;
Pallisgaard, N ;
Kjeldsen, E ;
Holm, MS ;
Nielsen, JL ;
Hokland, P .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 67 (5-6) :302-308
1